<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://fn.bmj.com">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition current issue</title>
<link>http://fn.bmj.com</link>
<description>Archives of Disease in Childhood - Fetal and Neonatal Edition RSS feed -- current issue</description>
<prism:eIssn>1468-2052</prism:eIssn>
<prism:coverDisplayDate>May  1 2013 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Archives of Disease in Childhood - Fetal and Neonatal Edition</prism:publicationName>
<prism:issn>1359-2998</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F189?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F190?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F192?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F195?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F201?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F205?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F212?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F218?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F222?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F228?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F233?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F239?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F241?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F244?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F249?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F256?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F260?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/264?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F265?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F267?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F269?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F272?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F276?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F278?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F279?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F280?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/98/3/F281?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition</title>
<url>http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://fn.bmj.com</link>
</image>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F189?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F189?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Chasing an ASTEC</st> <p>The ASTECS trial, first planned almost 20&nbsp;years ago, opened in 1995. It is still of interest now because of the lingering concern that the improvement in short term outcomes from the administration of antenatal betamethasone to mothers undergoing elective caesarean section at term might be counterbalanced by adverse effects that might only become manifest in the long term. Such effects might plausibly include more (or less) atopic disease, or altered cognitive function. So Stutchfield <I>et al</I> are to be congratulated on their tenacious follow up of the subjects of the original trial to evaluate rates of asthma and atopic disease, and measures of behavioural and educational function, in subjects now aged between 8 and 15&nbsp;years. The results are reassuring: there is a good case for using antenatal betamethasone for term elective caesarean section, without concerns about long term harm. <b><I><addart type="iti" doi="10.1136/archdischild-2012-303157">See page F195</addart></I></b></p> </sec>...]]></description>
<dc:creator><![CDATA[Ward Platt, M.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304118</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2013-304118</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Fantoms</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F189</prism:startingPage>
<prism:endingPage>F189</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F190?rss=1">
<title><![CDATA[The antenatal diagnosis of fetal anomaly: where to deliver the baby?]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F190?rss=1</link>
<description><![CDATA[ <p>The question as to where to deliver the baby arises whenever there is an antenatal diagnosis of significant fetal anomaly. The decision should in theory be made collaboratively between parents, fetal medicine specialists, neonatologists and relevant paediatric specialists (eg, cardiologists, surgeons, nephrologists); but the discussion, and the decision, can be distorted by a variety of factors. These include misperceptions of safety, based on anecdotes of unfortunate experiences; the desire of regional fetal medicine specialists to see the outcomes of their diagnoses; and real or imaginary doubts about the ability of a referring centre to undertake initial stabilisation of a neonate with a potentially complicated problem.</p> <p>Patient safety is clearly a very important issue, but statements about safety should be based on hard data rather than anecdote or uninformed opinion. For this reason, the paper by Kelsall et al in this edition is a welcome addition to the literature on...]]></description>
<dc:creator><![CDATA[Platt, M. P. W.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301837</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301837</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Patients, Open access, Echocardiography, Hospice, Radiology, Clinical diagnostic tests, Radiology (diagnostics), Informed consent, Legal and forensic medicine, Medical error/ patient safety]]></dc:subject>
<dc:title><![CDATA[The antenatal diagnosis of fetal anomaly: where to deliver the baby?]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F190</prism:startingPage>
<prism:endingPage>F191</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F192?rss=1">
<title><![CDATA[The role of colony stimulating factors and immunoglobulin in the prevention and treatment of neonatal infection]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F192?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Introduction</st> <p>Bacterial systemic infection (SI) remains one of the unresolved challenges of neonatal intensive care, directly and indirectly responsible for infant death and impaired neuro-developmental outcomes. The incidence increases with lower gestational age and birth weight. Reported rates of SI range from 21% in very low birth weight (VLBW) infants, 33% for infants &lt;28&nbsp;weeks and 41% in small for gestation preterm infants.<cross-ref type="bib" refid="R1">1&ndash;3</cross-ref><cross-ref type="bib" refid="R2"></cross-ref><cross-ref type="bib" refid="R3"></cross-ref> Death is more frequent following gram negative than gram positive infection, and ranges from 18% mortality in VLBW infants to 31% in small for gestational age (SGA) infants following culture positive SI.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R3">3</cross-ref> Longer term outcomes of SI have been less frequently reported. The National Institute of Child Health and Development (NICHD) neonatal network reported significant impaired psychomotor development index in 26% of infants &lt;1000&nbsp;g surviving to 2&nbsp;years following SI in contrast to 13% in those...]]></description>
<dc:creator><![CDATA[Carr, R.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301269</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301269</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Immunology (including allergy), Drugs: infectious diseases, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[The role of colony stimulating factors and immunoglobulin in the prevention and treatment of neonatal infection]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Leading articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F192</prism:startingPage>
<prism:endingPage>F194</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F195?rss=1">
<title><![CDATA[Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F195?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To determine whether antenatal betamethasone prior to elective term caesarean section (CS) affects long term behavioural, cognitive or developmental outcome, and whether the risk of asthma or atopic disease is reduced.</p>
</sec>
<sec><st>Design</st>
<p>A questionnaire based follow-up of a multicentre randomised controlled trial (Antenatal Steroids for Term Elective Caesarean Section, BMJ 2005).</p>
</sec>
<sec><st>Setting</st>
<p>Four UK study centres from the original trial.</p>
</sec>
<sec><st>Participants</st>
<p>862 participants from the four largest recruiting centres, 92% of the original study. 824 (96%) were traced and 799 (93%) were successfully contacted. Fifty-one percent (407/799) completed and returned the questionnaire. The children were aged 8&ndash;15&nbsp;years (median 12.2&nbsp;years, 52% girls). 386 gave consent to contact schools with 352 (91%) reports received.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Questionnaires including a strengths and difficulties questionnaire, International Study of Asthma and Allergies in Childhood, general health and school performance.</p>
</sec>
<sec><st>Results</st>
<p>There were no significant differences between <unl>c</unl>hildren whose mothers received betamethasone and controls for the mean total strengths and difficulties questionnaire scores and subscores for hyperactivity, emotional symptoms, prosocial behaviour, conduct or peer problems. 25 (12%) children whose mothers received betamethasone had reported learning difficulties compared with 27 (14%) control children. The proportion of children who achieved standard assessment tests KS2 exams level 4 or above for mathematics, English or science was similar as were the rates of ever reported wheeze (30% vs 30%), asthma (24% vs 21%), eczema (34% vs 37%) and hay fever (25% vs 27%).</p>
</sec>
<sec><st>Conclusions</st>
<p>Antenatal betamethasone did not result in any adverse outcomes or reduction in asthma or atopy. It should be considered for elective CS at 37&ndash;38&nbsp;weeks of gestation.</p>
</sec>
<sec><st>Trial registration:</st>
<p>Original trial was preregistration, the trial publication is BMJ. 2005 Sep 24;331(7518):662.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Stutchfield, P. R., Whitaker, R., Gliddon, A. E., Hobson, L., Kotecha, S., Doull, I. J. M.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303157</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-303157</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Editor's choice, Immunology (including allergy), Child health, Disability, Asthma, Dermatology, Ear, nose and throat/otolaryngology]]></dc:subject>
<dc:title><![CDATA[Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F195</prism:startingPage>
<prism:endingPage>F200</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F201?rss=1">
<title><![CDATA[Predicting death or major neurodevelopmental disability in extremely preterm infants born in Australia]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F201?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The aim of this study was to determine if the National Institute of Child Health and Human Development (NICHD) calculator, designed to predict mortality or neurosensory disability in infants 22&ndash;25 weeks&rsquo; gestation, was valid for contemporary Australian infants.</p>
</sec>
<sec><st>Method</st>
<p>Outcome data at 2&nbsp;years of age for 114 infants who were liveborn in Victoria, Australia, in 2005, between 22 and 25 completed weeks&rsquo; gestation, weighing 401&ndash;1000&nbsp;g at birth, and free of lethal anomalies, were entered into the NICHD online calculator. Predicted outcomes were then compared with the actual outcomes.</p>
</sec>
<sec><st>Results</st>
<p>Of the 114 infants, 99 (87%) were inborn and 15 (13%) were outborn. The overall prediction of death for inborn infants was 47.1% compared with the actual death rate to 2&nbsp;years of age of 49.5%. The area under the curve (AUC) was 0.803 (95% CI 0.718 to 0.888; p&lt;0.001) for mortality, comparable with the AUC for the NICHD study (AUC: 0.753; 95% CI 0.737 to 0.769; p&lt;0.001). The accuracy for predicting death was not as precise for outborn infants (AUC: 0.643; 95% CI 0.337 to 0.949; p=0.36). The calculator overestimated the combined outcome of death or survival with major disability at 72.0%, compared with an actual rate of 60.5%.</p>
</sec>
<sec><st>Conclusions</st>
<p>The NICHD outcome estimator was helpful in predicting mortality for inborn infants, 22&ndash;25&nbsp;weeks&rsquo; gestation, but was less precise for outborn infants. It overestimated the combined outcome of death or major disability in infants born in Victoria, Australia, in 2005.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Boland, R. A., Davis, P. G., Dawson, J. A., Doyle, L. W., for the Victorian Infant Collaborative Study Group]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-301628</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-301628</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies]]></dc:subject>
<dc:title><![CDATA[Predicting death or major neurodevelopmental disability in extremely preterm infants born in Australia]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F201</prism:startingPage>
<prism:endingPage>F204</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F205?rss=1">
<title><![CDATA[Neurodevelopmental outcomes of extremely premature infants conceived after assisted conception: a population based cohort study]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F205?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To compare neurodevelopmental outcomes of extremely preterm infants conceived after assisted conception (AC) compared with infants conceived spontaneously (non-AC).</p>
</sec>
<sec><st>Design</st>
<p>Population-based retrospective cohort study.</p>
</sec>
<sec><st>Setting</st>
<p>Geographically defined area in New South Wales and the Australian Capital Territory, Australia served by a network of 10 neonatal intensive care units.</p>
</sec>
<sec><st>Patients</st>
<p>Infants &lt;29&nbsp;weeks&rsquo; gestation born between 1998 and 2004.</p>
</sec>
<sec><st>Intervention</st>
<p>At 2&ndash;3&nbsp;years corrected age, 1473 children were assessed with either the Griffiths Mental Developmental Scales or the Bayley Scales of Infant Development.</p>
</sec>
<sec><st>Main outcome measure</st>
<p>Moderate/severe functional disability defined as developmental delay (Griffiths General Quotient or Bayley Mental Developmental Index &gt;2 SD below the mean), cerebral palsy (unable to walk without aids), deafness (bilateral hearing aids or cochlear implant) or blindness (visual acuity &lt;6/60 in the better eye).</p>
</sec>
<sec><st>Results</st>
<p>Mortality and age at follow-up were comparable between the AC and non-AC groups. Developmental outcome was evaluated in 217 (86.5%) AC and 1256 (71.7%) non-AC infants. Using multivariate adjusted analysis, infants born after in-vitro fertilisation at 22&ndash;26&nbsp;weeks&rsquo; gestation (adjusted OR 1.79, 95% CI 1.05 to 3.05, p=0.03) but not at 27&ndash;28&nbsp;weeks&rsquo; gestation (adjusted OR 0.81, 95% CI 0.37 to 1.77; p=0.59) had higher rate of functional disability than those born after spontaneous conception.</p>
</sec>
<sec><st>Conclusions</st>
<p>AC is associated with adverse neurodevelopmental outcome among high risk infants born at 22&ndash;26&nbsp;weeks&rsquo; gestation. This finding warrants additional exploration.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Abdel-Latif, M. E., Bajuk, B., Ward, M., Oei, J. L., Badawi, N., and the NSW and ACT Neonatal Intensive Care Units Audit Group]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302040</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302040</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Eye Diseases, Epidemiologic studies, Cerebral palsy, Pregnancy, Reproductive medicine, Ophthalmology, Child and adolescent psychiatry (paedatrics), Child health, Developmental paediatrics, Infant health, Neonatal health, Disability, Ear, nose and throat/otolaryngology]]></dc:subject>
<dc:title><![CDATA[Neurodevelopmental outcomes of extremely premature infants conceived after assisted conception: a population based cohort study]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F205</prism:startingPage>
<prism:endingPage>F211</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F212?rss=1">
<title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F212?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To characterise the actuarial day-by-day survival of premature infants in a geographically defined population.</p>
</sec>
<sec><st>Setting</st>
<p>10 Neonatal Intensive Care Units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective analysis of prospectively collected data as part of NICUs' data collection in NSW and ACT.</p>
</sec>
<sec><st>Subjects</st>
<p>Premature infants born at 22<sup>+0</sup> to 31<sup>+6</sup> weeks' gestation between January 1997 and December 2006 and admitted to one of the 10 NICUs in NSW and ACT.</p>
</sec>
<sec><st>Outcome</st>
<p>Actuarial day-by-day survival to discharge from NICU.</p>
</sec>
<sec><st>Results</st>
<p>Survival to discharge after initiation of neonatal intensive care ranges from 30.0% at 23 weeks' gestation to 98.8% at 31 weeks. Actuarial day-by-day survival increased across all gestations. This improvement was most notable among the babies who were born &lt;26 weeks gestation.</p>
</sec>
<sec><st>Conclusion</st>
<p>Preterm infants who survive the first few postnatal days have considerable chances of long-term survival. It is important to revise the information stored regarding chances of survival so it covers chances at regular intervals, especially after the first few days of life.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Abdel-Latif, M. E., Kecskes, Z., Bajuk, B., On behalf of the NSW and the ACT Neonatal Intensive Care Audit Group]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.210856</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.210856</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Short reports</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F212</prism:startingPage>
<prism:endingPage>F217</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F218?rss=1">
<title><![CDATA[Outcome of infants with prenatally diagnosed congenital heart disease delivered outside specialist paediatric cardiac centres]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F218?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine the outcome of neonates with a suspected antenatal diagnosis of congenital heart disease (CHD) who were delivered away from a paediatric cardiothoracic centre and were initially managed in a level 3 Neonatal Intensive Care Unit.</p>
</sec>
<sec><st>Methods</st>
<p>An 18-year ongoing study conducted in a single institution.</p>
</sec>
<sec><st>Results</st>
<p>Between 1992 and 2009, 143 fetuses with suspected CHD were identified, and 124 babies were delivered locally. 13 babies with a normal postnatal echocardiogram and six with isolated arrhythmias were excluded from the study. Structural CHD was confirmed in 105 infants; of these, 94 (90%) survived the neonatal period. Of the 11 neonatal deaths, only four of these infants underwent surgery; most had additional risk factors including: prematurity, very low birth weight, and genetic and other structural congenital anomalies.</p>
</sec>
<sec><st>Conclusions</st>
<p>This study demonstrates that appropriately selected infants with antenatally diagnosed CHD can be safely delivered and initially managed in a non-cardiac centre during their neonatal period. Deliveries need to be carefully planned with close collaboration among neonatologists, obstetricians, paediatric cardiologists, mid-wives and parents.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Anagnostou, K., Messenger, L., Yates, R., Kelsall, W.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300488</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300488</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Drugs: cardiovascular system, Echocardiography, Radiology, Clinical diagnostic tests, Radiology (diagnostics), Arrhythmias]]></dc:subject>
<dc:title><![CDATA[Outcome of infants with prenatally diagnosed congenital heart disease delivered outside specialist paediatric cardiac centres]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F218</prism:startingPage>
<prism:endingPage>F221</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F222?rss=1">
<title><![CDATA[Effect of sustained inflation duration; resuscitation of near-term asphyxiated lambs]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F222?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The 2010 ILCOR neonatal resuscitation guidelines do not specify appropriate inflation times for the initial lung inflations in apnoeic newborn infants. The authors compared three ventilation strategies immediately after delivery in asphyxiated newborn lambs.</p>
</sec>
<sec><st>Design</st>
<p>Experimental animal study.</p>
</sec>
<sec><st>Setting</st>
<p>Facility for animal research.</p>
</sec>
<sec><st>Subjects</st>
<p>Eighteen near-term lambs (weight 3.5&ndash;3.9 kg) delivered by caesarean section.</p>
</sec>
<sec><st>Interventions</st>
<p>Asphyxia was induced by occluding the umbilical cord and delaying ventilation onset (10&ndash;11 min) until mean carotid blood pressure (CBP) was &le;22 mm Hg. Animals were divided into three groups (n=6) and ventilation started with: (1) inflation times of 0.5 s at a ventilation rate 60/min, (2) five 3 s inflations or (3) a single 30 s inflation. Subsequent ventilation used inflations at 0.5 s at 60/min for all groups.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Times to reach a heart rate (HR) of 120 bpm and a mean CBP of 40 mm Hg. Secondary outcome was change in lung compliance.</p>
</sec>
<sec><st>Results</st>
<p>Median time to reach HR 120 bpm and mean CBP 40 mm Hg was significantly shorter in the single 30 s inflation group (8 s and 74 s) versus the 5<FONT FACE="arial,helvetica">x</FONT>3 s inflation group (38 s and 466 s) and the conventional ventilation group (64 s and 264 s). Lung compliance was significantly better in the single 30 s inflation group.</p>
</sec>
<sec><st>Conclusion</st>
<p>A single sustained inflation of 30 s immediately after birth improved speed of circulatory recovery and lung compliance in near-term asphyxiated lambs. This approach for neonatal resuscitation merits further investigation.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Klingenberg, C., Sobotka, K. S., Ong, T., Allison, B. J., Schmolzer, G. M., Moss, T. J. M., Polglase, G. R., Dawson, J. A., Davis, P. G., Hooper, S. B.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-301787</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-301787</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Hypertension, Experiments in vivo, Resuscitation, Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Effect of sustained inflation duration; resuscitation of near-term asphyxiated lambs]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F222</prism:startingPage>
<prism:endingPage>F227</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F228?rss=1">
<title><![CDATA[Oxygen saturation after birth in preterm infants treated with continuous positive airway pressure and air: assessment of gender differences and comparison with a published nomogram]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F228?rss=1</link>
<description><![CDATA[
<sec><st>Aims</st>
<p>The goal of the study was to compare preductal SpO<SUB>2</SUB> in the first 10&nbsp;min after birth in preterm infants treated with non-invasive continuous positive airway pressure (CPAP) and air with a published nomogram of preductal SpO<SUB>2</SUB> in preterm infants who received no medical intervention, and to examine gender differences.</p>
</sec>
<sec><st>Design</st>
<p>Prospective observational study.</p>
</sec>
<sec><st>Patients and methods</st>
<p>We enrolled infants of &le;32&nbsp;weeks gestation who were spontaneously breathing with heart rate &gt;100&nbsp;bpm, and treated with face mask CPAP and air during postnatal stabilisation. SpO<SUB>2</SUB> limits were targeted at &ge;75% at 5&nbsp;min and &ge;85% at 10&nbsp;min and heart rate at &gt;100&nbsp;bpm. FIO<SUB>2</SUB> was titrated against SpO<SUB>2</SUB>. Preductal SpO<SUB>2</SUB>, airway pressure and FIO<SUB>2</SUB> were recorded with a data acquisition system from birth until stabilisation. Babies receiving supplemental oxygen (&gt;21%), positive pressure ventilation, were intubated and/or received chest compressions or drugs were excluded.</p>
</sec>
<sec><st>Results</st>
<p>Measurements were obtained in 102 babies with median gestational age of 29 (range: 24&ndash;31) weeks. Median SpO<SUB>2</SUB> was significantly higher in the observational group than in the reference range at 3&nbsp;min (82% (CI 71% to 85%) vs 76% (CI 67% to 83%); p&lt;0.05), at 4&nbsp;min (87% (CI 81% to 90%) vs 81% (CI 72% to 88%); p&lt;0.05), at 5&nbsp;min (92% (CI 88% to 95%) vs 86% (CI 80% to 92%); p&lt;0.05), at 6&nbsp;min (94% (CI 90% to 97%) vs 90% (CI 81% to 95%); p&lt;0.05), at 7&nbsp;min (95% (CI 92% to 97%) vs 92% (CI 85% to 95%); p&lt;0.05), at 8&nbsp;min (96% (CI 93% to 98%) vs 92% (CI 87% to 96%); p&lt;0.05) and at 9&nbsp;min (97% (CI 92% to 99%) vs 93% (CI 87% to 96%); p&lt;0.05). Female babies achieved targeted SpO<SUB>2</SUB> significantly earlier than male babies.</p>
</sec>
<sec><st>Conclusions</st>
<p>Preterm babies receiving CPAP and air and especially female subjects achieve reference oxygen saturation more rapidly than spontaneously breathing preterm babies without respiratory aid.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Vento, M., Cubells, E., Escobar, J. J., Escrig, R., Aguar, M., Brugada, M., Cernada, M., Saenz, P., Izquierdo, I.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302369</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302369</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Oxygen saturation after birth in preterm infants treated with continuous positive airway pressure and air: assessment of gender differences and comparison with a published nomogram]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F228</prism:startingPage>
<prism:endingPage>F232</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F233?rss=1">
<title><![CDATA[The placenta in infants >36 weeks gestation with neonatal encephalopathy: a case control study]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F233?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine placental characteristics associated with neonatal encephalopathy (NE) and correlate these with short- and long-term neurodevelopmental outcome.</p>
</sec>
<sec><st>Design</st>
<p>Case/control study.</p>
</sec>
<sec><st>Setting</st>
<p>Neonatal Intensive Care Unit, Rotunda Hospital, Dublin, Ireland.</p>
</sec>
<sec><st>Patients</st>
<p>Newborns &ge;36 weeks gestation, with NE (cases). Healthy term newborns (controls).</p>
</sec>
<sec><st>Interventions</st>
<p>Placental pathology was obtained from the official placental report. Brain MRI was blindly reviewed. Children were assessed using a variety of standardised assessments. Data were analysed using multinomial logistic regression analysis.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>RRR for grade of encephalopathy. OR for neurodevelopmental outcome.</p>
</sec>
<sec><st>Results</st>
<p>Placental reports were available on 141 cases (76 grade 1; 46 grade 2; 19 grade 3) and 309 control infants. Meconium phagocytosis, haemorrhage, raised placental to birth weight ratio and/or markers of infection/inflammation were independently associated with NE and showed a synergistic effect, when combined, for short- and long-term impairments.</p>
</sec>
<sec><st>Conclusions</st>
<p>Evaluation of the mechanisms leading to the placental characteristics identified may help to characterise the causal pathway of NE.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hayes, B. C., Cooley, S., Donnelly, J., Doherty, E., Grehan, A., Madigan, C., McGarvey, C., Mulvany, S., Ryan, S., Gillian, J., Geary, M. P., Matthews, T. G., King, M. D.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-301992</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-301992</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Neuroimaging]]></dc:subject>
<dc:title><![CDATA[The placenta in infants >36 weeks gestation with neonatal encephalopathy: a case control study]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F233</prism:startingPage>
<prism:endingPage>F239</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F239?rss=1">
<title><![CDATA[Multiple brain abscesses and facial palsy in a neonate]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F239?rss=1</link>
<description><![CDATA[ <sec> <p>A term, 3.5-kg male neonate was referred to our hospital on day 5 of life for respiratory distress, hypoglycaemia and feed intolerance. There was no history of perinatal asphyxia or birth trauma. Investigations revealed thrombocytopaenia and coagulopathy with raised C reactive protein and leucocytosis. Chest x-ray was suggestive of pneumonia. He was started on Vancomycin and Piperacillin-Tazobactum for suspected sepsis. His blood culture grew <I>Klebsiella pneumoniae</I>, sensitive to Imipenem. Cerebrospinal fluid (CSF) examination was normal. On day 10 of life, he was noted to have right-sided lower motor neuron type facial palsy (<cross-ref type="fig" refid="FETALNEONATAL2012301702F1">figure 1</cross-ref>). Rest of the neurological examination was unremarkable. Ultrasonography of brain revealed few hyperechoic lesions in the right basal ganglia and bilateral frontal regions. For a better delineation of these lesions, a MRI of brain was done, which revealed multiple small ring-enhancing lesions in bilateral frontal and parietal lobes, right basal ganglia and...]]></description>
<dc:creator><![CDATA[Louis, D., Balasubramanian, K., Sundaram, V.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301702</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301702</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Drugs: infectious diseases, Meningitis, Pneumonia (infectious disease), TB and other respiratory infections, Infection (neurology), Radiology, Pneumonia (respiratory medicine), Dentistry and oral medicine, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics), Trauma, Diabetes, Metabolic disorders, Injury]]></dc:subject>
<dc:title><![CDATA[Multiple brain abscesses and facial palsy in a neonate]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F239</prism:startingPage>
<prism:endingPage>F240</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F241?rss=1">
<title><![CDATA[In vitro comparison of neonatal suction catheters using simulated 'pea soup' meconium]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F241?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>A variety of suction catheters (type, size and design) are recommended for oropharyngeal suctioning of meconium during newborn resuscitation, but it is not known which performs best. In this study we compared different sizes of soft catheters, the Yankauer (YK) and the portable bulb syringe (BS), in suctioning a solution of varying viscosity.</p>
</sec>
<sec><st>Methods</st>
<p>Simulated meconium (SM) was made using commercial canned pea soup in two strengths, full-strength thick-particulate (TP) and 50% strained soup diluted with water, that is, thin-non-particulate (TnP), with saline as a control. A 20&nbsp;ml aliquot of solution was suctioned over 5&nbsp;s with each device using an electrical suction pump set at two different pressures, 100 and 150&nbsp;mm&nbsp;Hg (21&nbsp;kpa). In addition, the negative pressure of five BSs was measured in order to compare generated pressures with the alternative devices.</p>
</sec>
<sec><st>Results</st>
<p>The YK and BS suctioned almost 100% of saline, while the 6F and 8F catheters suctioned 50% and 75% saline, respectively. The YK suctioned 100% of TnP, saline and 30% of TP. At reduced suction pressures (100 and 50&nbsp;mm&nbsp;Hg) the YK also suctioned all TnP. The 12F and 14F catheters suctioned a minimal amount of TP, whereas YK was the most efficient, suctioning 30% of TP. The mean negative pressure generated with five BSs was 78 and 71&nbsp;mm&nbsp;Hg by a male and female operator, respectively.</p>
</sec>
<sec><st>Conclusions</st>
<p>The YK and BS outperform the catheters in suctioning SM. The YK is the best for TP, but all devices perform poorly in suctioning fluid of this consistency.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Zareen, Z., Hawkes, C. P., Krickan, E. R., Dempsey, E. M., Ryan, C. A.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302495</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302495</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Resuscitation]]></dc:subject>
<dc:title><![CDATA[In vitro comparison of neonatal suction catheters using simulated 'pea soup' meconium]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F241</prism:startingPage>
<prism:endingPage>F243</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F244?rss=1">
<title><![CDATA[Effect of therapeutic touch on brain activation of preterm infants in response to sensory punctate stimulus: a near-infrared spectroscopy-based study]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F244?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The purpose of this study was to determine whether therapeutic touch in preterm infants can ameliorate their sensory punctate stimulus response in terms of brain activation measured by near-infrared spectroscopy.</p>
</sec>
<sec><st>Methods</st>
<p>The study included 10 preterm infants at 34&ndash;40&nbsp;weeks&rsquo; corrected age. Oxyhaemoglobin (Oxy-Hb) concentration, heart rate (HR), arterial oxygen saturation (SaO<SUB>2</SUB>) and body movements were recorded during low-intensity sensory punctate stimulation for 1&nbsp;s with and without therapeutic touch by a neonatal development specialist nurse. Each stimulation was followed by a resting phase of 30&nbsp;s. All measurements were performed with the infants asleep in the prone position.</p>
</sec>
<sec><st>Results</st>
<p>sensory punctate stimulus exposure significantly increased the oxy-Hb concentration but did not affect HR, SaO<SUB>2</SUB> and body movements. The infants receiving therapeutic touch had significantly decreased oxy-Hb concentrations over time.</p>
</sec>
<sec><st>Conclusions</st>
<p>Therapeutic touch in preterm infants can ameliorate their sensory punctate stimulus response in terms of brain activation, indicated by increased cerebral oxygenation. Therefore, therapeutic touch may have a protective effect on the autoregulation of cerebral blood flow during sensory punctate stimulus in neonates.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Honda, N., Ohgi, S., Wada, N., Loo, K. K., Higashimoto, Y., Fukuda, K.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301469</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301469</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal health, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Effect of therapeutic touch on brain activation of preterm infants in response to sensory punctate stimulus: a near-infrared spectroscopy-based study]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F244</prism:startingPage>
<prism:endingPage>F248</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F249?rss=1">
<title><![CDATA[Neonatal infections in China, Malaysia, Hong Kong and Thailand]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F249?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Neonatal sepsis is a major cause of neonatal deaths in Asia but data remain scarce. We aimed to investigate the causative organisms and antibiotic resistance in neonatal care units in China, Malaysia, Hong Kong and Thailand.</p>
</sec>
<sec><st>Methods</st>
<p>Prospective cohort study of neonatal sepsis defined as positive culture of a single potentially pathogenic organism from blood or cerebrospinal fluid differentiated into early-onset sepsis (EOS) occurring &lt;3&nbsp;days of birth and late-onset sepsis (LOS) &ge;3&nbsp;days after birth.</p>
</sec>
<sec><st>Results</st>
<p>During the study period, there were 963 episodes of neonatal sepsis. The incidence of EOS was 0.62 (95% CI 0.45 to 0.82) per 1000 live births or 4.91 (95% CI 4.22 to 5.68) per 1000 admissions while the incidence of LOS was 5.00 (95% CI 4.51 to 5.53) per 1000 live births or 21.22 (95% CI 19.79 to 22.77) per 1000 admissions. The incidence of Group B <I>Streptococcus</I> (GBS) sepsis was low but remained the most common single pathogen for EOS among inborn babies. <I>Klebsiella</I> spp. was the most common Gram-negative organism causing most deaths. The case-fatality was 7.0% (95% CI 3.9% to 12.0%) for EOS and 16.0% (95% CI 13.7% to 19.0%) for LOS, and was significantly different between participating units after adjusting for potential confounders. Of all Gram-negative organisms, 47%, 37% and 32% were resistant to third-generation cephalosporins, gentamicin or both, respectively.</p>
</sec>
<sec><st>Conclusions</st>
<p>The pattern of EOS in Asian settings is similar to that in industrialised countries with low incidence of GBS sepsis. The important features of neonatal sepsis in Asia are the burden of <I>Klebsiella</I> spp. and high level of antibiotic resistance. These should be addressed while developing measures to reduce neonatal mortality due to infection.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Al-Taiar, A., Hammoud, M. S., Cuiqing, L., Lee, J. K. F., Lui, K.-M., Nakwan, N., Isaacs, D.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-301767</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-301767</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drugs: infectious diseases]]></dc:subject>
<dc:title><![CDATA[Neonatal infections in China, Malaysia, Hong Kong and Thailand]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F249</prism:startingPage>
<prism:endingPage>F255</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F256?rss=1">
<title><![CDATA[Outcome of infants presenting with echogenic bowel in the second trimester of pregnancy]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F256?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Fetal echogenic bowel (FEB) is a soft marker found on second trimester sonography. Our main aim was to determine the outcome of infants who presented with FEB and secondarily to identify additional sonographic findings that might have clinical relevance for the prognosis.</p>
</sec>
<sec><st>Design</st>
<p>We reviewed all pregnancies in which the diagnosis FEB was made in our Fetal Medicine Unit during 2009&ndash;2010 (N=121). We divided all cases into five groups according to additional sonographic findings. Group 1 consisted of cases of isolated FEB, group 2 of FEB associated with dilated bowels, group 3 of FEB with one or two other soft markers, group 4 of FEB with major congenital anomalies or three or more other soft markers, and group 5 consisted of FEB with isolated intrauterine growth restriction (IUGR).</p>
</sec>
<sec><st>Results</st>
<p>Of 121 cases, five were lost to follow-up. Of the remaining 116 cases, 48 (41.4%) were assigned to group 1, 15 (12.9%) to group 2, 15 (12.9%) to group 3, 27 (23.2%) to group 4, and 11 (9.5%) to group 5. The outcome for group 1 was uneventful. In group 2 and 3, two anomalies, anorectal malformation and cystic fibrosis, were detected postnatally (6.7%). In group 4, mortality and morbidity were high (78% resp. 22%). Group 5 also had high mortality (82%) and major morbidity (18%).</p>
</sec>
<sec><st>Conclusions</st>
<p>If FEB occurs in isolation, it is a benign condition carrying a favourable prognosis. If multiple additional anomalies or early IUGR are observed, the prognosis tends to be less favourable to extremely poor.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Buiter, H. D., Holswilder-Olde Scholtenhuis, M. A. G., Bouman, K., van Baren, R., Bilardo, C. M., Bos, A. F.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302017</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302017</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Pancreas and biliary tract, Epidemiologic studies, Pregnancy, Reproductive medicine, Cystic fibrosis]]></dc:subject>
<dc:title><![CDATA[Outcome of infants presenting with echogenic bowel in the second trimester of pregnancy]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F256</prism:startingPage>
<prism:endingPage>F259</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F260?rss=1">
<title><![CDATA[A novel approach to standardised recording of bleeding in a high risk neonatal population]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F260?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Bleeding assessment tools have been developed in other specialties to standardise the recording of bleeding for clinical haemostatic outcomes in transfusion trials, but such tools have not been developed for routine use in neonatology.</p>
</sec>
<sec><st>Aim</st>
<p>The objective of this study was to develop, refine and evaluate a neonatal bleeding assessment tool (NeoBAT) to standardise the clinical recording of bleeding in premature and term neonates in an intensive care setting.</p>
</sec>
<sec><st>Methods</st>
<p>This prospective neonatal international multicentre study included all episodes of bleeding in infants admitted to the intensive/high dependency care nursery over a 2&ndash;4-week period. The NeoBAT was developed to record neonatal bleeding episodes. We tested its reliability and reproducibility with duplicate assessments.</p>
</sec>
<sec><st>Results</st>
<p>Duplicate assessments revealed 98% concordance. Bleeding occurred in 25% (37/146) of infants overall and was most common in preterm infants. 11% (16/146) infants had major/severe bleeds, 1% (2/146) moderate and 13% (19/146) minor bleeds.</p>
</sec>
<sec><st>Conclusions</st>
<p>Bleeding is common in premature and term neonates admitted to intensive/high dependency care nurseries. This novel bleeding assessment tool facilitates prospective recording of bleeding events in neonatal intensive care settings and may allow standardised bleeding assessments in this high risk population.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Venkatesh, V., Curley, A., Khan, R., Clarke, P., Watts, T., Josephson, C., Muthukumar, P., New, H., Seeney, F., Morris, S., Stanworth, S.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302443</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302443</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[A novel approach to standardised recording of bleeding in a high risk neonatal population]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F260</prism:startingPage>
<prism:endingPage>F263</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/264?rss=1">
<title><![CDATA[Holoprosencephaly with premaxillary agenesis in a prehistoric skull]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/264?rss=1</link>
<description><![CDATA[ <sec> <p>Holoprosencephaly (HPE) is a severe condition that results from failed or incomplete forebrain cleavage early in gestation.<cross-ref type="bib" refid="R1">1</cross-ref> The classification proposed by DeMyer is widely used, which includes alobar, semilobar and lobar HPE depending on the degree of the midline deficiencies of the telencephalon.<cross-ref type="bib" refid="R2">2</cross-ref> Facial anomalies associated with HPE are usually classified as cyclopia, ethmocephaly, cebocephaly, premaxillary agenesis with median cleft lip and less severe manifestations.<cross-ref type="bib" refid="R3">3</cross-ref><cross-ref type="fig" refid="fetalneonatal2012302123F1"></cross-ref><cross-ref type="fig" refid="fetalneonatal2012302123F2"></cross-ref></p> <p>We present a 1500-year-old skull of a 5-year-old child (ossification and tooth eruption), who presented a premaxillary agenesis and ocular hypotelorism suggesting the diagnosis of semilobar HPE. The presentation of HPE has been extensively studied by Cohen (2009). He describes cyclopia as the main manifestation.<cross-ref type="bib" refid="R4">4</cross-ref> Although the presence of HPE and premaxillary agenesis has been reported, this case corresponds to the Lima culture, a pre-Inca culture that developed in the central...]]></description>
<dc:creator><![CDATA[Pachajoa, H., Rodriguez, C. A.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-302123</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-302123</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Drugs: CNS (not psychiatric), Reproductive medicine, Child health, Dentistry and oral medicine, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Holoprosencephaly with premaxillary agenesis in a prehistoric skull]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>264</prism:startingPage>
<prism:endingPage>264</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F265?rss=1">
<title><![CDATA[Averaging time, desaturation level, duration and extent]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F265?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Pulse oximeter saturation values are usually obtained by averaging over preceding measurements. This study investigates the dynamics between the averaging time and desaturation level, duration and extent.</p>
</sec>
<sec><st>Methods and results</st>
<p>Prospective observational study of 15 preterm infants. Oxygen saturation was recorded for 168&nbsp;h using a pulse oximeter. The raw red-to-infrared data were reprocessed using seven different averaging times to determine the number of desaturations below four thresholds and for seven different minimal desaturation durations. The total number of desaturations &lt;80% was 339 with an averaging time of 16&nbsp;s and 1958 with an averaging time of 3&nbsp;s (minimal event duration &gt;0&nbsp;s). There was a significantly lower pulse oximeter saturation nadir with the shorter averaging time, while the maximum duration was significantly longer when using a 16&nbsp;s averaging time.</p>
</sec>
<sec><st>Conclusions</st>
<p>When using pulse oximeters, more attention should be given to averaging time and duration of desaturations.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Vagedes, J., Poets, C. F., Dietz, K.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302543</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302543</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Averaging time, desaturation level, duration and extent]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Short research reports</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F265</prism:startingPage>
<prism:endingPage>F266</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F267?rss=1">
<title><![CDATA[Avoiding sedation in research MRI and spectroscopy in infants: our approach, success rate and prevalence of incidental findings]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F267?rss=1</link>
<description><![CDATA[
<p>Performing magnetic resonance investigations in a paediatric population can be difficult; image acquisition is commonly complicated by movement artefact and non-compliance. Sedation is widely used for clinically indicated investigations, but there is controversy when used for research imaging. Over a 10-year period we have performed whole body MRI on over 450 infants and hepatic magnetic resonance spectroscopy on over 270 infants. These investigations have been accomplished without the use of sedation in infants up to 3&nbsp;months of age. Our overall success rate in achieving good quality images free of movement artefact is 94%. The prevalence of incidental findings on whole body (excluding brain) MRI in our cohort was 0.8%. We conclude that the use of sedation for research MRI in this group is not necessary. Our approach to MRI in infancy is also described.</p>
]]></description>
<dc:creator><![CDATA[Gale, C., Jeffries, S., Logan, K. M., Chappell, K. E., Uthaya, S. N., Modi, N.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302536</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-302536</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Other anaesthesia]]></dc:subject>
<dc:title><![CDATA[Avoiding sedation in research MRI and spectroscopy in infants: our approach, success rate and prevalence of incidental findings]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Short research reports</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F267</prism:startingPage>
<prism:endingPage>F268</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F269?rss=1">
<title><![CDATA[Patent ductus arteriosus: time to grasp the nettle?]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F269?rss=1</link>
<description><![CDATA[
<p>The management of patent ductus arteriosus is controversial, and there are diverse approaches to treatment, ranging from very conservative management through to early and aggressive securing of ductus closure, either pharmacologically or surgically. This lack of consensus on best management reflects a paucity of high quality randomised controlled trials, with many published studies focusing on establishing points of treatment, rather than looking for benefits of intervention over more conservative management. Despite this lack of good evidence views on ductus management can be entrenched, with accompanying loss of equipoise. This review looks at our current situation with regard to ductus arteriosus management and the need for good quality trials especially in the light of other published studies, concerning postnatal steroids, caffeine and oxygen which have demonstrated unexpected benefits &ndash; or sometimes unexpected harm &ndash; from long-familiar drugs.</p>
]]></description>
<dc:creator><![CDATA[Smith, C. L., Kissack, C. M.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301129</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301129</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Patent ductus arteriosus: time to grasp the nettle?]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F269</prism:startingPage>
<prism:endingPage>F271</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F272?rss=1">
<title><![CDATA[Osteopenia in preterm infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F272?rss=1</link>
<description><![CDATA[ <sec> <p>In the newborn preterm infant a combination of inadequate reserves and increased loss of essential minerals is common and frequently compounded by difficulties in obtaining an intake sufficient to replace losses and restore reserves. Deficiencies in calcium and phosphate and disturbed balance between them are frequently encountered, and may lead to significant impairment of bone deposition. Osteopenia of prematurity &ndash; also known as neonatal rickets, rickets of prematurity or neonatal metabolic bone disease &ndash; is a common and important concern in neonatology, and effective management is hindered by difficulties in accurately assessing calcium and phosphate status and the &lsquo;quality&rsquo; of bone deposition.</p> <p>It is well known that preterm infants are at risk of reduced bone mineral content (BMC) and subsequent bone disease and that many factors may contribute to this. The majority of calcium and phosphate accretion and bone mineralisation occur in the third trimester of pregnancy and...]]></description>
<dc:creator><![CDATA[Harrison, C. M., Gibson, A. T.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301025</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301025</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Osteopenia in preterm infants]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F272</prism:startingPage>
<prism:endingPage>F275</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F276?rss=1">
<title><![CDATA[Fetal surgery for neural tube defects]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F276?rss=1</link>
<description><![CDATA[ <sec> <p>The <I>New England Journal of Medicine</I> recently reported on a large clinical trial describing subjects with meningomyelocele (MMC) that were randomised to surgical repair either in the fetal period or to standard postnatal repair.<cross-ref type="bib" refid="R1">1</cross-ref> This report has generated enormous excitement, but also vigorous debate. This study &ndash; the &lsquo;MOMS&rsquo; trial (Management of Meningomyelocele Study) &ndash; is the first to demonstrate that fetal intervention might alter the natural history of a congenital neurologic malformation. Meningomyeloceles are the most common form of neural tube defects and result from disturbed neurulation during the third and fourth weeks of gestation.<cross-ref type="bib" refid="R2">2</cross-ref> Although the incidence varies markedly across different regions, MMC occurs in approximately 300 000 infants worldwide each year.<cross-ref type="bib" refid="R3">3</cross-ref> The incidence of live births with MMC has decreased significantly in recent decades through combined effects of improved diagnosis and dietary supplementation. Improved prenatal detection by serum markers...]]></description>
<dc:creator><![CDATA[Niforatos, N., du Plessis, A. J.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301397</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301397</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Fetal surgery for neural tube defects]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F276</prism:startingPage>
<prism:endingPage>F278</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F278?rss=1">
<title><![CDATA[Happy cord]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F278?rss=1</link>
<description><![CDATA[
<p><fn><no>Provenance and peer review</no><p>Not commissioned; externally peer reviewed.</p>
</fn></p>
<p>
<fig loc="float" id="FETALNEONATAL2012302496F1">
<link locator="fetalneonatal2012302496f01"></fig>
</p>
]]></description>
<dc:creator><![CDATA[Dix, L., Megevand, C., Laubscher, B.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-302496</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-302496</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology]]></dc:subject>
<dc:title><![CDATA[Happy cord]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F278</prism:startingPage>
<prism:endingPage>F278</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F279?rss=1">
<title><![CDATA[Maternal adiposity and newborn vascular health]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F279?rss=1</link>
<description><![CDATA[ <sec id="fetalneonatal-2012-303566s1"> <p>The prevalence of overweight and obesity in women of childbearing age is up to 60% in developed nations.<cross-ref type="bib" refid="fetalneonatal-2012-303566R1">1</cross-ref> We sought to determine whether maternal adiposity is associated with aortic wall thickening in newborns, prior to prolonged postnatal exposure to potential confounders; and if so, whether this association is independent of birth weight, a known risk factor for later cardiovascular disease.</p> <p>Twenty-three pregnant women, age 35.6 years (SD 4.8; range 27.0&ndash;44.6), were recruited at 16.3&nbsp;weeks gestation (SD 2.2; range 11.4&ndash;20.6) from The Women's Hospital, Melbourne, Australia. Women who had quit smoking in the previous 6&nbsp;months were excluded; however those who continued to smoke were not. Maternal height and weight were measured at study entry. Overweight and obesity was defined as a body mass index (BMI)&ge;25&nbsp;kg/m<sup>2</sup>, which we believe will not differ substantially from prepregnancy BMI given that weight gain is slow during the first trimester, and...]]></description>
<dc:creator><![CDATA[Begg, L. M., Palma-Dias, R., Wang, J., Chin-Dusting, J. P. F., Skilton, M. R.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303566</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-303566</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Maternal adiposity and newborn vascular health]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F279</prism:startingPage>
<prism:endingPage>F280</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F280?rss=1">
<title><![CDATA[Whole-body cooling in neonatal encephalopathy using phase changing material]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F280?rss=1</link>
<description><![CDATA[ <sec id="fetalneonatal-2013-303840fetalneonatal2013303840s1"> <p>Whole body cooling improves outcomes after neonatal encephalopathy (NE) in high-income countries<cross-ref type="bib" refid="fetalneonatal-2013-303840fetalneonatal2013303840R1">1</cross-ref>; however, effective low technology cooling devices suitable for use in low and middle-income countries (LMIC) is lacking.<cross-ref type="bib" refid="fetalneonatal-2013-303840fetalneonatal2013303840R2">2</cross-ref> Although cooling using ice is effective in tertiary neonatal units, dangerous temperature fluctuations may occur if continuous temperature monitoring and nursing support is not available.<cross-ref type="bib" refid="fetalneonatal-2013-303840fetalneonatal2013303840R2">2</cross-ref> Phase changing materials (PCM) are made of salt hydride, fatty acid, and esters or paraffin, and melt at a set point; in the process they can store or release large amounts of energy (<cross-ref type="fig" refid="FETALNEONATAL2013303840F1">figure 1</cross-ref>). We examined the feasibility of administering whole body cooling using PCM.</p> <p>We randomly (Minimisation software; Simin, UCL) allocated 33 infants with NE (Thompsons encephalopathy score &gt;5) aged &lt;6&nbsp;h, admitted to the neonatal unit at Calicut Medical College, Kerala, India, to whole-body cooling by a PCM mattress, or to standard care,...]]></description>
<dc:creator><![CDATA[Thayyil, S., Shankaran, S., Wade, A., Cowan, F. M., Ayer, M., Satheesan, K., Sreejith, C., Eyles, H., Taylor, A. M., Bainbridge, A., Cady, E. B., Robertson, N. J., Price, D., Balraj, G.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303840</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2013-303840</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Whole-body cooling in neonatal encephalopathy using phase changing material]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F280</prism:startingPage>
<prism:endingPage>F281</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/98/3/F281?rss=1">
<title><![CDATA[PAI-1/t-PA ratio in cord blood: a potential index of brain haemorrhage risk in extreme preterms]]></title>
<link>http://fn.bmj.com/cgi/content/short/98/3/F281?rss=1</link>
<description><![CDATA[ <sec> <p>Although the incidence of subependymal haemorrhage/intraventricular haemorrhage (IVH)/intraparenchymal haemorrhage has decreased in recent years, it remains a good predictor of neurodevelopmental handicaps in very-preterm infants.<cross-ref type="bib" refid="fetalneonatal2012303603R1">1</cross-ref> Intraventricular blood leakage can result in hydrocephalus due to limited cerebrospinal fluid resorption, a consequence of fibrosis in the arachnoid granulation, subependymal basal lamina and perivascular spaces. The reference treatment approved for hydrocephalus is the ventriculoperitoneal shunt. A randomised trial of an alternative treatment procedure combining drainage and intraventricular fibrinolysis with recombinant tissue plasminogen activator (rt-PA) has been stopped because of haemorrhagic complications.</p> <p>t-PA binds to low-density lipoprotein (LDL)-related receptor protein-1 (LRP1) promoting the induction of matrix metalloproteinase (MMP) 9. In addition, t-PA cleavage of plasminogen initiates proteolytic MMP cascade, resulting in degradation of the extracellular vascular bed proteins, blood brain barrier leakage, and endothelial cell anoikis. Plasminogen activator inhibitor 1 (PAI-1) in the blood stream blocks t-PA proteolytic activity, and...]]></description>
<dc:creator><![CDATA[Leroux, P., Marret, S.]]></dc:creator>
<dc:date>2013-04-10T22:04:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303603</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2012-303603</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[PAI-1/t-PA ratio in cord blood: a potential index of brain haemorrhage risk in extreme preterms]]></dc:title>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F281</prism:startingPage>
<prism:endingPage>F282</prism:endingPage>
</item>
</rdf:RDF>